HealthSouth Rehabilitation Hospital of Western Massachusetts

Name :

HealthSouth Rehabilitation Hospital of Western Massachusetts

Address  :

14 Chestnut Place

Town  :

Ludlow

State  :

Massachusetts

Country  :

USA

Post Code:

01056

Phone  :

413 589 7581

Fax  :

413 589 1688

Web URL  :

Specialization
  • Neurologist
  • Orthopedics
  • Pulmonology
Facilities

Total Number Of Beds : 53


Description

HealthSouth Rehabilitation Hospital amp Outpatient Center
HealthSouth Rehabilitation Hospital of Western Massachusetts is a 53bed acute Rehabilitation Hospital located in Ludlow Massachusetts The facility has been operating for 14 years and has provided rehabilitative care to patients and families in the greater Springfield area with an outstanding reputation for attention to detail and compassion Because rehabilitation is HealthSouths primary focus our expert staff dedicates all their skills and knowledge to a single goal improving each patients functional abilities through intensive individualized therapeutic services Helping patients to attain that goal is enhanced by our longstanding relationships with other major healthcare facilities in Western Massachusetts HealthSouth Rehabilitation Hospital of Western Massachusetts is a member of HealthSouth Corporation the nations largest provider of physical rehabilitation services Through this network of rehabilitation hospital systems our patients and their families receive the expert rehabilitative care they need to get back to their lives
Recycled Kidney Successfully Implanted into 2nd Recipient after First Failed Transplant

Surgeons have successfully transplanted a kidney that had already been transplanted in one patient but started to fail into a second patient doctors reported on Wednesday In a report published in the the New England Journal of Medicine doctors documented the groundbreaking procedures of a kidney that had been transplanted twice in two weeks A... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More